Literature DB >> 782774

Intramuscular butorphanol and meperidine in postoperative pain.

M S Gilbert, R M Hanover, D S Moylan, F S Caruso.   

Abstract

Butorphanol, 1, 2, and 4 mg/70 kg, and meperidine, 40 and 80 mg/70 kg, were compared for analgesic activity and side effects in 104 hospitalized postoperative patients. Butorphanol proved to be 30 to 40 times as potent as meperidine on a weight basis. Both medications provided maximum pain relief approximately 1 hr after administration. The most common side effect in all groups was drowsiness.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782774     DOI: 10.1002/cpt1976203359

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

1.  Analgesic effectiveness of the narcotic agonist-antagonists.

Authors:  R W Houde
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 2.  Butorphanol: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-12       Impact factor: 9.546

Review 3.  Opioid agonist-antagonist drugs in acute and chronic pain states.

Authors:  P J Hoskin; G W Hanks
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

4.  The cardiovascular effects of high-dose butorphanol-nitrous oxide anaesthesia before and during operation.

Authors:  T H Stanley; P Reddy; S Gilmore; G Bennett
Journal:  Can Anaesth Soc J       Date:  1983-07

5.  The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.

Authors:  W C Shyu; K A Pittman; D S Robinson; R H Barbhaiya
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  The effects of age and sex on the systemic availability and pharmacokinetics of transnasal butorphanol.

Authors:  W C Shyu; E A Morgenthien; K A Pittman; R H Barbhaiya
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.